Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
159M
-
Number of holders
-
345
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
+2.22M
-
Total reported value, excl. options
-
$5.5B
-
Value change
-
+$76.1M
-
Put/Call ratio
-
0.55
-
Number of buys
-
166
-
Number of sells
-
-167
-
Price
-
$44.96
Significant Holders of IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) as of Q1 2021
443 filings reported holding IONS - IONIS PHARMACEUTICALS INC - COMMON STOCK as of Q1 2021.
IONIS PHARMACEUTICALS INC - COMMON STOCK (IONS) has 345 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
of 159M outstanding shares and own 77.08% of the company stock.
Largest 10 shareholders include FMR LLC (21.1M shares), VANGUARD GROUP INC (12.6M shares), PRICE T ROWE ASSOCIATES INC /MD/ (12.6M shares), BlackRock Inc. (9.81M shares), Bellevue Group AG (8.98M shares), Clearbridge Investments, LLC (7.4M shares), ARK Investment Management LLC (5.14M shares), STATE STREET CORP (3.41M shares), Invesco Ltd. (2.36M shares), and JPMORGAN CHASE & CO (1.96M shares).
This table shows the top 345 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.